Tanezumab

A humanized monoclonal antibody directed against nerve growth factor (NGF), a modulator of nociceptor function, with potential analgesic activity. Tanezumab binds to NGF and prevents NGF binding to its high affinity, membrane-bound, catalytic receptor tropomyosin-related kinase A (TrkA), which is present on sympathetic and sensory neurons; reduced stimulation of TrkA by NGF inhibits the pain-transmission activities of these neurons. NGF, a neurotrophin, is critical to the growth and maintenance of sympathetic and sensory neurons. In addition, NGF may induce mast cells to release inflammatory proteins and may induce the upregulation of substance P and other pain-related peptides in sympathetic and sensory neurons. Upon neurotrophin binding, TrkA phosphorylates itself and members of the MAPK pathway, mediating the multiple neuronal effects of NGF. (NCI Thesaurus)

YOU MAY ALSO LIKE

Tanexaban

An orally active inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity. Tanexaban is extensively metabolized in the liver to…

Tanespimycin

A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. Tanespimycin helps cause the breakdown…

Tandutinib

A substance being studied in the treatment of some types of cancer. It may stop cancer cell growth by blocking certain…

Tandem Repeat Variation

An inherited polymorphism in eukaryotic DNA that results from variations in the number of tandem repeat nucleotide sequences, which are end-to-end adjacent…

Tandem Mass Spectrometry Scoring Engine

A software program that compares the mass of peptide fragments found by tandem mass spectrometry with the expected peptides based on the…

Tandem Mass Spectrometry

Mass spectrometers coupled in series. The targeted compound is selectively ionized, and its characteristic ions are separated from others in the…